DEVELOPMENT OF CONTINUOUS C-PEPTIDE MONITORING TECHNOLOGIES
Up to $900,000 in total funding over a maximum period of three years. Applications of increased scope (time and/or budget) will be considered where there is a strong justification. - Thursday, December 04, 2025 (LOI)
Breakthrough T1D, USThe aim is to develop continuous C-peptide monitoring (CCPM).
